Benjamin Diamond, MD

Articles by Benjamin Diamond, MD

Benjamin Diamond, MD, of Memorial Sloan Kettering Cancer Center

Dr. Diamond on the Need to Integrate MRD Testing Into Clinical Trials in Multiple Myeloma

ByBenjamin Diamond, MD

May 21st 2021

Benjamin Diamond, MD, discusses the need to integrate minimal residual disease testing into clinical trials in multiple myeloma.

Benjamin Diamond, MD, discusses the rationale for examining long-term minimal residual disease in patients with multiple myeloma.

Dr. Diamond on the Rationale for Examining Long-Term MRD in Myeloma

ByBenjamin Diamond, MD

May 5th 2021

Benjamin Diamond, MD, discusses the rationale for examining long-term minimal residual disease in patients with multiple myeloma.

Latest Updated Articles

Dr. Diamond on the Rationale for Examining Long-Term MRD in Myeloma
May 5th 2021
Dr. Diamond on the Need to Integrate MRD Testing Into Clinical Trials in Multiple Myeloma
May 21st 2021

Trending on OncLive

Five Under 5: Top Oncology Videos for the Week of 8/31/26

FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer

Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC

B7-H4–Targeted ADCs Signal a New Frontier for Platinum-Resistant Ovarian and Endometrial Cancer

The OncFive: Top Oncology Articles for the Week of 8/30